The abundance of progenitor CD8+T cells and DC cells in tumours was similar between patients who responded to immunotherapy and those who did not, but there was significant enrichment of CD4+ helper T cells in patients who were effective [90]. This evidence concerns the gene CD8A and neoplasm.